Who Will Lead FDA In The Future? Succession Plan Is Not Enough, GAO Says
In its latest report card on FDA, the Government Accountability Office examines the agency's management of such challenges as recruiting and retaining its workforce and communicating with the public
You may also be interested in...
At Hill briefing, Rep. DeLauro praises the Sentinel initiative and Commissioner Hamburg but expresses dismay about the "knowledge shortfall" at the agency.
Pfizer Says Government Investigations Must Be Avoided, Since "There Is No Way Of Winning" Once They Start
Pfizer would like to avoid being in the government hot seat again. After paying the largest fine ever in a government investigation, the company has instituted procedures to prevent future problems with its marketing and sales practices
Jenkins Suggests "Complete Response" Letter Transparency Could Prompt Better Drug Applications, Faster Reviews
If FDA's transparency initiative results in the public release of "complete response" letters, Office of New Drugs Director John Jenkins sees a possible side benefit for the agency